A set of recommendations on the management of patients with rheumatic and musculoskeletal diseases has been developed by EULAR . These recommendations focus on prevention of COVID-19; managing patients in general; and managing patients who have been infected or have been in contact with a COVID-19 patient. The recommendations were simultaneously published in the Annals of the Rheumatic Diseases .
Despite the sparse evidence combined with the tremendous time pressure under which these recommendations were made, EULAR was able to develop a preliminary set of recommendations on management of patients with rheumatic and musculoskeletal diseases in the COVID-19 era.
Prof. Robert Landewé (Academic Medical Center Amsterdam and Zuyderland Medical Center Heerlen) emphasized that they are indeed preliminary and that updates are eagerly awaited. “However, for the time being, it will have to do.”
The 13 recommendations are based on 4 themes:
Full recommendations can be found online here.
1. Landewé RBM. Provisional recommendations COVID-19. EULAR COVID-19 Recommendations. EULAR 2020.
2. Landewé RBM, et al. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. 2020;annrheumdis-2020-217877.